Although previous studies [1, 26, 27] have reported higher expression of the PBK/TOPK mRNA and protein in tumor tissues than in adjacent noncancerous tissues from different tumors, this study was the first pan-cancer analysis of PBK/TOPK and enabled us to observe the expression across all cancers. The gene discussed is PBK; the disease is neoplasm.